Search results for: “keytruda”
-
Blog
Dax Bykerk’s Immunotherapy Story
Melanoma | Diagnosed Age 34 It takes about an hour and a half at best, and then you’re… -
Blog
Henrik Vad Madsen’s Immunotherapy Story
Melanoma | Diagnosed 2003 My approach was to say: I have cancer, but I want to have a… -
Blog
Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer
-
Blog
T.J. Sharpe’s Immunotherapy Story
Melanoma | Diagnosed 2012 When I was in the hospital, I made a vow that when I was… -
Blog
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
-
Blog
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.
-
Blog
CNN Highlights Cancer Immunotherapy Advances, CRI’s Pioneering Role
First-line lung cancer immunotherapy approval results from century-long effort to harness the immune system to fight cancer.
-
Blog
Checkpoint Inhibitors Benefit Lung Cancer Patients in Clinical Trials
Patients with metastatic non-small cell lung cancer could soon have a new first-line immunotherapy treatment option.
-
Blog
CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints
The latest advances in using new checkpoint drugs to target LAG-3, Nrp1, IL-35R, CD36, and mitochondrial metabolism.